ANN MARIE HEMBROUGH: Open Payments
NPI 1699931725 · LAGUNA BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,095 in 140 payments from 22 companies in 2025. Trend: 2023 $1,573 · 2024 $2,873 · 2025 $3,095
Food & beverage: $2,916Education: $179
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $663 |
| Galderma Laboratories, L.P. | 15 | $441 |
| Janssen Biotech, Inc. | 15 | $420 |
| Regeneron Healthcare Solutions, Inc. | 14 | $359 |
| GENZYME CORPORATION | 4 | $227 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $119 |
| Botanix SB Inc | 6 | $110 |
| Amgen Inc. | 6 | $107 |
| PFIZER INC. | 5 | $85 |
| Arcutis Biotherapeutics, Inc. | 5 | $84 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, NEMLUVIO, RINVOQ, SOFDRA, Otezla, Zoryve.
Industry payments across CA — which companies pay providers there.
